// App-Quantinova.ai

: Resistant Graves’ thyrotoxicosis with adverse cardiovascular effects

Researchers

Presenter

  • Scott Williams

Principal Investigators

  • Helmine Kejem

  • Jael Nizza

  • Upendram Srinivas Shankar

Medical Centers

  • Arrowe Park Hospital, Upton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Endocrine/metabolic Diseases (ME)

Disease

  • Ventricular arrhythmias

  • Myocardial infarction

  • Congestive heart failure

  • Thyrotoxicosis

  • Cardiac arrest

  • Hypothyroidism

  • Venous thrombosis

  • Coronavirus disease

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Levothyroxine

  • Prednisolone

  • Propranolol

  • Amiodarone Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved